 | • レポートコード：MRC2-11QY12425 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は体外毒性試験のグローバル市場について調査・分析したレポートです。種類別（細胞アッセイ、生化学的アッセイ、シリカ中、生体外）市場規模、用途別（全身毒性、皮膚毒性、内分泌障害、眼毒性、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別体外毒性試験の競争状況、市場シェア ・世界の体外毒性試験市場：種類別市場規模 2015年-2020年（細胞アッセイ、生化学的アッセイ、シリカ中、生体外） ・世界の体外毒性試験市場：種類別市場規模予測 2021年-2026年（細胞アッセイ、生化学的アッセイ、シリカ中、生体外） ・世界の体外毒性試験市場：用途別市場規模 2015年-2020年（全身毒性、皮膚毒性、内分泌障害、眼毒性、その他） ・世界の体外毒性試験市場：用途別市場規模予測 2021年-2026年（全身毒性、皮膚毒性、内分泌障害、眼毒性、その他） ・北米の体外毒性試験市場分析：米国、カナダ ・ヨーロッパの体外毒性試験市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの体外毒性試験市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の体外毒性試験市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの体外毒性試験市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Covance、GE Healthcare、Quest Diagnostics Inc.、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories、Catalent Pharma Solutions、Cyprotex、Agilent Technologies、Charles River Laboratories、Merck KgaA、Eurofins Scientific Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells.
Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and high costs associated with conventional animal tests are poised to boost the inclination towards in-vitro toxicology assays.
Market Analysis and Insights: Global In-vitro Toxicology Testing Market
The global In-vitro Toxicology Testing market size is projected to reach US$ 11300 million by 2026, from US$ 10560 million in 2020, at a CAGR of 6.5%% during 2021-2026.
Global In-vitro Toxicology Testing Scope and Market Size
In-vitro Toxicology Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Covance
GE Healthcare
Quest Diagnostics Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Catalent Pharma Solutions
Cyprotex
Agilent Technologies
Charles River Laboratories
Merck KgaA
Eurofins Scientific Inc.
Market segment by Type, the product can be split into
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo
Market segment by Application, split into
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In-vitro Toxicology Testing Revenue
1.4 Market by Type
1.4.1 Global In-vitro Toxicology Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cellular Assay
1.4.3 Biochemical Assay
1.4.4 In Silica
1.4.5 Ex-vivo
1.5 Market by Application
1.5.1 Global In-vitro Toxicology Testing Market Share by Application: 2020 VS 2026
1.5.2 Systemic Toxicology
1.5.3 Dermal Toxicity
1.5.4 Endorine Disruption
1.5.5 Occular Toxicity
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Toxicology Testing Market Perspective (2015-2026)
2.2 Global In-vitro Toxicology Testing Growth Trends by Regions
2.2.1 In-vitro Toxicology Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In-vitro Toxicology Testing Historic Market Share by Regions (2015-2020)
2.2.3 In-vitro Toxicology Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In-vitro Toxicology Testing Market Growth Strategy
2.3.6 Primary Interviews with Key In-vitro Toxicology Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Toxicology Testing Players by Market Size
3.1.1 Global Top In-vitro Toxicology Testing Players by Revenue (2015-2020)
3.1.2 Global In-vitro Toxicology Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global In-vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In-vitro Toxicology Testing Market Concentration Ratio
3.2.1 Global In-vitro Toxicology Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In-vitro Toxicology Testing Revenue in 2019
3.3 In-vitro Toxicology Testing Key Players Head office and Area Served
3.4 Key Players In-vitro Toxicology Testing Product Solution and Service
3.5 Date of Enter into In-vitro Toxicology Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global In-vitro Toxicology Testing Historic Market Size by Type (2015-2020)
4.2 Global In-vitro Toxicology Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global In-vitro Toxicology Testing Market Size by Application (2015-2020)
5.2 Global In-vitro Toxicology Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In-vitro Toxicology Testing Market Size (2015-2020)
6.2 In-vitro Toxicology Testing Key Players in North America (2019-2020)
6.3 North America In-vitro Toxicology Testing Market Size by Type (2015-2020)
6.4 North America In-vitro Toxicology Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe In-vitro Toxicology Testing Market Size (2015-2020)
7.2 In-vitro Toxicology Testing Key Players in Europe (2019-2020)
7.3 Europe In-vitro Toxicology Testing Market Size by Type (2015-2020)
7.4 Europe In-vitro Toxicology Testing Market Size by Application (2015-2020)
8 China
8.1 China In-vitro Toxicology Testing Market Size (2015-2020)
8.2 In-vitro Toxicology Testing Key Players in China (2019-2020)
8.3 China In-vitro Toxicology Testing Market Size by Type (2015-2020)
8.4 China In-vitro Toxicology Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan In-vitro Toxicology Testing Market Size (2015-2020)
9.2 In-vitro Toxicology Testing Key Players in Japan (2019-2020)
9.3 Japan In-vitro Toxicology Testing Market Size by Type (2015-2020)
9.4 Japan In-vitro Toxicology Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia In-vitro Toxicology Testing Market Size (2015-2020)
10.2 In-vitro Toxicology Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In-vitro Toxicology Testing Market Size by Type (2015-2020)
10.4 Southeast Asia In-vitro Toxicology Testing Market Size by Application (2015-2020)
11 India
11.1 India In-vitro Toxicology Testing Market Size (2015-2020)
11.2 In-vitro Toxicology Testing Key Players in India (2019-2020)
11.3 India In-vitro Toxicology Testing Market Size by Type (2015-2020)
11.4 India In-vitro Toxicology Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America In-vitro Toxicology Testing Market Size (2015-2020)
12.2 In-vitro Toxicology Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America In-vitro Toxicology Testing Market Size by Type (2015-2020)
12.4 Central & South America In-vitro Toxicology Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott In-vitro Toxicology Testing Introduction
13.1.4 Abbott Revenue in In-vitro Toxicology Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Covance
13.2.1 Covance Company Details
13.2.2 Covance Business Overview
13.2.3 Covance In-vitro Toxicology Testing Introduction
13.2.4 Covance Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.2.5 Covance Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview
13.3.3 GE Healthcare In-vitro Toxicology Testing Introduction
13.3.4 GE Healthcare Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Quest Diagnostics Inc.
13.4.1 Quest Diagnostics Inc. Company Details
13.4.2 Quest Diagnostics Inc. Business Overview
13.4.3 Quest Diagnostics Inc. In-vitro Toxicology Testing Introduction
13.4.4 Quest Diagnostics Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.4.5 Quest Diagnostics Inc. Recent Development
13.5 Thermo Fisher Scientific Inc.
13.5.1 Thermo Fisher Scientific Inc. Company Details
13.5.2 Thermo Fisher Scientific Inc. Business Overview
13.5.3 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Introduction
13.5.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.5.5 Thermo Fisher Scientific Inc. Recent Development
13.6 Bio-Rad Laboratories
13.6.1 Bio-Rad Laboratories Company Details
13.6.2 Bio-Rad Laboratories Business Overview
13.6.3 Bio-Rad Laboratories In-vitro Toxicology Testing Introduction
13.6.4 Bio-Rad Laboratories Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.6.5 Bio-Rad Laboratories Recent Development
13.7 Catalent Pharma Solutions
13.7.1 Catalent Pharma Solutions Company Details
13.7.2 Catalent Pharma Solutions Business Overview
13.7.3 Catalent Pharma Solutions In-vitro Toxicology Testing Introduction
13.7.4 Catalent Pharma Solutions Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.7.5 Catalent Pharma Solutions Recent Development
13.8 Cyprotex
13.8.1 Cyprotex Company Details
13.8.2 Cyprotex Business Overview
13.8.3 Cyprotex In-vitro Toxicology Testing Introduction
13.8.4 Cyprotex Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.8.5 Cyprotex Recent Development
13.9 Agilent Technologies
13.9.1 Agilent Technologies Company Details
13.9.2 Agilent Technologies Business Overview
13.9.3 Agilent Technologies In-vitro Toxicology Testing Introduction
13.9.4 Agilent Technologies Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.9.5 Agilent Technologies Recent Development
13.10 Charles River Laboratories
13.10.1 Charles River Laboratories Company Details
13.10.2 Charles River Laboratories Business Overview
13.10.3 Charles River Laboratories In-vitro Toxicology Testing Introduction
13.10.4 Charles River Laboratories Revenue in In-vitro Toxicology Testing Business (2015-2020)
13.10.5 Charles River Laboratories Recent Development
13.11 Merck KgaA
10.11.1 Merck KgaA Company Details
10.11.2 Merck KgaA Business Overview
10.11.3 Merck KgaA In-vitro Toxicology Testing Introduction
10.11.4 Merck KgaA Revenue in In-vitro Toxicology Testing Business (2015-2020)
10.11.5 Merck KgaA Recent Development
13.12 Eurofins Scientific Inc.
10.12.1 Eurofins Scientific Inc. Company Details
10.12.2 Eurofins Scientific Inc. Business Overview
10.12.3 Eurofins Scientific Inc. In-vitro Toxicology Testing Introduction
10.12.4 Eurofins Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020)
10.12.5 Eurofins Scientific Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. In-vitro Toxicology Testing Key Market Segments
Table 2. Key Players Covered: Ranking by In-vitro Toxicology Testing Revenue
Table 3. Ranking of Global Top In-vitro Toxicology Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In-vitro Toxicology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cellular Assay
Table 6. Key Players of Biochemical Assay
Table 7. Key Players of In Silica
Table 8. Key Players of Ex-vivo
Table 9. Global In-vitro Toxicology Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global In-vitro Toxicology Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global In-vitro Toxicology Testing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global In-vitro Toxicology Testing Market Share by Regions (2015-2020)
Table 13. Global In-vitro Toxicology Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global In-vitro Toxicology Testing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. In-vitro Toxicology Testing Market Growth Strategy
Table 19. Main Points Interviewed from Key In-vitro Toxicology Testing Players
Table 20. Global In-vitro Toxicology Testing Revenue by Players (2015-2020) (Million US$)
Table 21. Global In-vitro Toxicology Testing Market Share by Players (2015-2020)
Table 22. Global Top In-vitro Toxicology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicology Testing as of 2019)
Table 23. Global In-vitro Toxicology Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players In-vitro Toxicology Testing Product Solution and Service
Table 26. Date of Enter into In-vitro Toxicology Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 29. Global In-vitro Toxicology Testing Market Size Share by Type (2015-2020)
Table 30. Global In-vitro Toxicology Testing Revenue Market Share by Type (2021-2026)
Table 31. Global In-vitro Toxicology Testing Market Size Share by Application (2015-2020)
Table 32. Global In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 33. Global In-vitro Toxicology Testing Market Size Share by Application (2021-2026)
Table 34. North America Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 36. North America In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 37. North America In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 38. North America In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 39. North America In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 40. Europe Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 42. Europe In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 43. Europe In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 44. Europe In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 45. Europe In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 46. China Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 47. China Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 48. China In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 49. China In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 50. China In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 51. China In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 52. Japan Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 54. Japan In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 55. Japan In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 56. Japan In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 57. Japan In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 60. Southeast Asia In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 62. Southeast Asia In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 64. India Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 65. India Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 66. India In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 67. India In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 68. India In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 69. India In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 70. Central & South America Key Players In-vitro Toxicology Testing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players In-vitro Toxicology Testing Market Share (2019-2020)
Table 72. Central & South America In-vitro Toxicology Testing Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America In-vitro Toxicology Testing Market Share by Type (2015-2020)
Table 74. Central & South America In-vitro Toxicology Testing Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America In-vitro Toxicology Testing Market Share by Application (2015-2020)
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott Product
Table 79. Abbott Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 80. Abbott Recent Development
Table 81. Covance Company Details
Table 82. Covance Business Overview
Table 83. Covance Product
Table 84. Covance Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 85. Covance Recent Development
Table 86. GE Healthcare Company Details
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Product
Table 89. GE Healthcare Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 90. GE Healthcare Recent Development
Table 91. Quest Diagnostics Inc. Company Details
Table 92. Quest Diagnostics Inc. Business Overview
Table 93. Quest Diagnostics Inc. Product
Table 94. Quest Diagnostics Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 95. Quest Diagnostics Inc. Recent Development
Table 96. Thermo Fisher Scientific Inc. Company Details
Table 97. Thermo Fisher Scientific Inc. Business Overview
Table 98. Thermo Fisher Scientific Inc. Product
Table 99. Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 100. Thermo Fisher Scientific Inc. Recent Development
Table 101. Bio-Rad Laboratories Company Details
Table 102. Bio-Rad Laboratories Business Overview
Table 103. Bio-Rad Laboratories Product
Table 104. Bio-Rad Laboratories Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 105. Bio-Rad Laboratories Recent Development
Table 106. Catalent Pharma Solutions Company Details
Table 107. Catalent Pharma Solutions Business Overview
Table 108. Catalent Pharma Solutions Product
Table 109. Catalent Pharma Solutions Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 110. Catalent Pharma Solutions Recent Development
Table 111. Cyprotex Business Overview
Table 112. Cyprotex Product
Table 113. Cyprotex Company Details
Table 114. Cyprotex Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 115. Cyprotex Recent Development
Table 116. Agilent Technologies Company Details
Table 117. Agilent Technologies Business Overview
Table 118. Agilent Technologies Product
Table 119. Agilent Technologies Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 120. Agilent Technologies Recent Development
Table 121. Charles River Laboratories Company Details
Table 122. Charles River Laboratories Business Overview
Table 123. Charles River Laboratories Product
Table 124. Charles River Laboratories Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 125. Charles River Laboratories Recent Development
Table 126. Merck KgaA Company Details
Table 127. Merck KgaA Business Overview
Table 128. Merck KgaA Product
Table 129. Merck KgaA Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 130. Merck KgaA Recent Development
Table 131. Eurofins Scientific Inc. Company Details
Table 132. Eurofins Scientific Inc. Business Overview
Table 133. Eurofins Scientific Inc. Product
Table 134. Eurofins Scientific Inc. Revenue in In-vitro Toxicology Testing Business (2015-2020) (Million US$)
Table 135. Eurofins Scientific Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Toxicology Testing Market Share by Type: 2020 VS 2026
Figure 2. Cellular Assay Features
Figure 3. Biochemical Assay Features
Figure 4. In Silica Features
Figure 5. Ex-vivo Features
Figure 6. Global In-vitro Toxicology Testing Market Share by Application: 2020 VS 2026
Figure 7. Systemic Toxicology Case Studies
Figure 8. Dermal Toxicity Case Studies
Figure 9. Endorine Disruption Case Studies
Figure 10. Occular Toxicity Case Studies
Figure 11. Others Case Studies
Figure 12. In-vitro Toxicology Testing Report Years Considered
Figure 13. Global In-vitro Toxicology Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global In-vitro Toxicology Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global In-vitro Toxicology Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global In-vitro Toxicology Testing Market Share by Players in 2019
Figure 18. Global Top In-vitro Toxicology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicology Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by In-vitro Toxicology Testing Revenue in 2019
Figure 20. North America In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America In-vitro Toxicology Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
体外毒性検査の世界市場（～2026年） In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early st…- 生体内毒性の世界市場（～2026年） In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals …
- 毒性検査の世界市場（～2026年） The toxicology testing market includes safety assessment of chemicals, drugs, cosmetic products, food additives, etc, without using animals as test models. This testing is performed on advance cell and tissue models to determine safety by studying the potential of the test substances to cause toxici…
- ADME毒性試験の世界市場（～2026年） ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage…
- IVD（体外診断）検査の世界市場（～2026年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…